Subsequent Events	4 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]
Subsequent Events	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date through the date the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustments or disclosure in the unaudited condensed financial statements. On July 6, 2026, the Company consummated the Initial Public Offering of 23,000,000 Units, which includes the full exercise by the underwriters of their over-allotment option of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $230,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 610,000 Private Placement Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,100,000. Each Private Placement Unit consists of one Class A ordinary share and one-third of one warrant. Of those 610,000 Private Placement Units, the Sponsor purchased 300,000 Private Placement Units, and Cohen, the representative of the underwriters, purchased 310,000 Private Placement Units. Following the closing of the Initial Public Offering, on July 6, 2026, an amount of $230,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units and portion of the sale of the Private Placement Units was placed in the Trust Account, with Continental Stock Transfer & Trust Company, acting as trustee. On July 6, 2026, the underwriters were paid in cash an underwriting discount of $5,100,000 simultaneously with the closing of the Initial Public Offering. The underwriters reimbursed certain of the Company’s offering expenses amounting to $500,000 for a net cash underwriting discount of $4,600,000. In addition, the underwriters are entitled to a deferred underwriting discount of $9,200,000 in the aggregate. On July 6, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result, the 1,000,000 Founder Shares are no longer subject to forfeiture.

Subsequent Events

4 Months Ended

Jun. 30, 2026

NOTE 9. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date through the date the unaudited condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustments or disclosure in the unaudited condensed financial statements.

On July 6, 2026, the Company consummated the Initial Public Offering of 23,000,000 Units, which includes the full exercise by the underwriters of their over-allotment option of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $230,000,000.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 610,000 Private Placement Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,100,000. Each Private Placement Unit consists of one Class A ordinary share and one-third of one warrant. Of those 610,000 Private Placement Units, the Sponsor purchased 300,000 Private Placement Units, and Cohen, the representative of the underwriters, purchased 310,000 Private Placement Units.

Following the closing of the Initial Public Offering, on July 6, 2026, an amount of $230,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units and portion of the sale of the Private Placement Units was placed in the Trust Account, with Continental Stock Transfer & Trust Company, acting as trustee.

On July 6, 2026, the underwriters were paid in cash an underwriting discount of $5,100,000 simultaneously with the closing of the Initial Public Offering. The underwriters reimbursed certain of the Company’s offering expenses amounting to $500,000 for a net cash underwriting discount of $4,600,000. In addition, the underwriters are entitled to a deferred underwriting discount of $9,200,000 in the aggregate.

On July 6, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result, the 1,000,000 Founder Shares are no longer subject to forfeiture.